Versant Ventures V, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Repare Therapeutics Inc., Aprea Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., and CRISPR Therapeutics AG.

2021 was Versant Ventures V, LLC's most active year for acquiring shares with 9 total transactions. Versant Ventures V, LLC's most active month to acquire stocks was the month of December. 2021 was Versant Ventures V, LLC's most active year for disposing of shares, totalling 3 transactions. Versant Ventures V, LLC's most active month to dispose stocks was the month of December. 2022 saw Versant Ventures V, LLC paying a total of $0.00 for 141,103 shares, this is the most they've acquired in one year. In 2022 Versant Ventures V, LLC cashed out on 141,103 shares for a total of $0.00, their largest year based on trade value.